Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: Findings from a claims database

Henriette Farkas, Donald Levy, Dylan Supina, Melvin Berger, Subhransu Prusty, Moshe Fridman

Research output: Article

Abstract

In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positively influenced by a replacement therapy with plasma derived C1-INH.

Original languageEnglish
Article number42
JournalAllergy, Asthma and Clinical Immunology
Volume16
Issue number1
DOIs
Publication statusPublished - máj. 27 2020

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: Findings from a claims database'. Together they form a unique fingerprint.

  • Cite this